合成生物学の世界市場

世界の合成生物学の市場規模は、2023年に154億米ドル、2024年の193億米ドルから、予測期間中はCAGR 26.1%で推移し、2029年末には616億米ドルの規模に達すると予測されています。

イネーブルド製品の部門は、2024年の101億米ドルから、CAGR 28.0％で推移し、2029年末には348億米ドルに達すると予測されています。また、イネーブリング製品の部門は、2024年の68億米ドルから、CAGR 25.1%で推移し、2029年末には210億米ドルに達すると予測されています。

当レポートでは、世界の合成生物学の市場を調査し、市場概要、市場影響因子および市場機会の分析、法規制環境、新興技術および技術開発の動向、市場規模の推移・予測、各種区分・地域別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

• 市場見通し
• 調査範囲
• 市場概要

第2章 市場概要

• 概要
• バリューチェーン分析
• 規制の枠組み
• 米国におけるGEMの規制
• 合成生物学が生物多様性保全に与える影響
• 直接的な影響
• 間接的な影響

第3章 市場力学

• 概要
• 市場促進要因
• 多様な分野における合成生物学の応用
• R&Dへの資金提供の拡大
• DNAシーケンシングのコスト低下
• 合成生物学分野における継続的イノベーション
• 市場抑制要因
• バイオセーフティ、バイオセキュリティ、倫理的問題
• 市場機会
• 代替燃料の需要増加
• 合成生物学における機械学習の活用

第4章 新たな動向と特許分析

• 新たな動向
• CRISPR-Casシステム
• 遺伝子ドライブ
• 拡張遺伝コード
• オプトジェネティクス
• 合成ゲノミクス
• 無細胞システム
• マイクロバイオームエンジニアリング
• 特許分析
• 主な付与特許
• 特許レビュー

第5章 市場セグメンテーション分析

• セグメンテーションの内訳
• 市場分析：製品タイプ別
• イネーブルド製品
• イネーブリング製品
• 生物学的成分
• 統合システム
• 市場分析：エンドユーザー別
• イネーブルド製品：エンドユーザー別
• イネーブリング製品エンドユーザー別
• 生物学的成分：エンドユーザー別
• 統合システム：エンドユーザー別
• 地理的内訳
• 市場分析：地域別
• 北米
• 欧州
• アジア太平洋
• その他の地域

第6章 競合情報

• 企業シェア分析
• 産業への投資

第7章 合成生物学市場における持続可能性：ESGの観点

• 概要
• バイオテクノロジー業界のESG動向
• ESGのリスクと課題
• ESGの視点
• 環境への影響
• 社会的影響
• ガバナンスと倫理的配慮

第8章 付録

• 調査手法
• 出典
• 頭字語
• 企業プロファイル
• AGILENT TECHNOLOGIES INC.
• AMYRIS
• CODEXIS INC.
• EUROFINS SCIENTIFIC
• GENSCRIPT
• GINKGO BIOWORKS
• MERCK KGAA
• THERMO FISHER SCIENTIFIC INC.
• TWIST BIOSCIENCE
• VIRIDOS

List of Tables

• Summary Table : Global Market for Synthetic Biology, by Product Type, Through 2029
• Table 1 : Challenges and Opportunities Posed by Synthetic Biology
• Table 2 : Applications of SynBio in Various Aspects
• Table 3 : Cost of Sequencing a Single Human Genome, 2001-2022
• Table 4 : Applications of ML/DL in SynBio
• Table 5 : List of Selected Patents Filed for Synthetic Biology, 2020
• Table 6 : List of Selected Patents Filed for Synthetic Biology, 2021
• Table 7 : List of Selected Patents Filed for Synthetic Biology, 2022
• Table 8 : List of Selected Patents Filed for Synthetic Biology, 2023
• Table 9 : List of Selected Patents Filed for Synthetic Biology, 2024
• Table 10 : Top IPCR Codes and Their Descriptions
• Table 11 : Global Synthetic Biology Market, by Product Type, Through 2029
• Table 12 : Biodiesel Fuel Performance Comparison, 2024
• Table 13 : Artemisinin Drug Production Comparison, 2024
• Table 14 : Global Synthetic Biology Market for Enabled Products, by Region, Through 2029
• Table 15 : Global Synthetic Biology Market for Enabling Products, by Product Type, Through 2029
• Table 16 : Global Synthetic Biology Market for Enabling Products, by Region, Through 2029
• Table 17 : Global Synthetic Biology Market for Biologic Components, by Product Type, Through 2029
• Table 18 : Global Synthetic Biology Market for Biologic Components, by Region, Through 2029
• Table 19 : Global Synthetic Biology Market for Integrated Systems, by Product Type, Through 2029
• Table 20 : Global Synthetic Biology Market for Integrated Systems, by Region, Through 2029
• Table 21 : Global Synthetic Biology Market, by End User, Through 2029
• Table 22 : Global Synthetic Biology Enabled Product Market, by End User, Through 2029
• Table 23 : Global Synthetic Biology Healthcare Market, by Sector, Through 2029
• Table 24 : Global Synthetic Biology Consumer Products Market, by Sector, Through 2029
• Table 25 : Global Synthetic Biology Food and Beverage Market, by Sector, Through 2029
• Table 26 : Factors for Synthetic Biology-Based Chemical Processes
• Table 27 : Global Synthetic Biology Industrial Chemicals Market, by Sector, Through 2029
• Table 28 : Global Synthetic Biology Agriculture Market, by Sector, Through 2029
• Table 29 : Global Synthetic Biology Enabling Product Market, by End User, Through 2029
• Table 30 : Global Synthetic Biology Biologic Component Market, by End User, Through 2029
• Table 31 : Global Synthetic Biology Integrated Systems Market, by End User, Through 2029
• Table 32 : Global Synthetic Biology Market, by Region, Through 2029
• Table 33 : North American Funding Organizations
• Table 34 : North American Synthetic Biology Market, by Country, Through 2029
• Table 35 : North American Synthetic Biology Market, by Product Type, Through 2029
• Table 36 : U.S. Synthetic Biology Market, by Product Type, Through 2029
• Table 37 : Canadian Synthetic Biology Market, by Product Type, Through 2029
• Table 38 : Mexican Synthetic Biology Market, by Product Type, Through 2029
• Table 39 : European Synthetic Biology Market, by Country, Through 2029
• Table 40 : European Synthetic Biology Market, by Product Type, Through 2029
• Table 41 : German Synthetic Biology Market, by Product Type, Through 2029
• Table 42 : U.K. Synthetic Biology Market, by Product Type, Through 2029
• Table 43 : French Synthetic Biology Market, by Product Type, Through 2029
• Table 44 : Spanish Synthetic Biology Market, by Product Type, Through 2029
• Table 45 : Italian Synthetic Biology Market, by Product Type, Through 2029
• Table 46 : Rest of the European Synthetic Biology Market, by Product Type, Through 2029
• Table 47 : Asia-Pacific Synthetic Biology Market, by Country, Through 2029
• Table 48 : Asia-Pacific Synthetic Biology Market, by Product Type, Through 2029
• Table 49 : Chinese Synthetic Biology Market, by Product Type, Through 2029
• Table 50 : Japanese Synthetic Biology Market, by Product Type, Through 2029
• Table 51 : Indian Synthetic Biology Market, by Product Type, Through 2029
• Table 52 : South Korean Synthetic Biology Market, by Product Type, Through 2029
• Table 53 : Rest of Asia-Pacific Synthetic Biology Market, by Product Type, Through 2029
• Table 54 : Rest of the World Synthetic Biology Market, by Product Type, Through 2029
• Table 55 : Selected Major Companies in Synthetic Biology, by Application, 2024
• Table 56 : Report Information Sources
• Table 57 : Glossary of Terms Used in the Global Synthetic Biology Market
• Table 58 : Agilent Technologies Inc.: Company Snapshot
• Table 59 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
• Table 60 : Agilent Technologies Inc.: Product Portfolio
• Table 61 : Agilent Technologies Inc.: News/Key Developments, 2023
• Table 62 : Amyris: Company Snapshot
• Table 63 : Amyris: Product Portfolio
• Table 64 : Amyris: News/Key Developments, 2021-2023
• Table 65 : Codexis Inc.: Company Snapshot
• Table 66 : Codexis Inc.: Financial Performance, FY 2022 and 2023
• Table 67 : Codexis Inc.: Product Portfolio
• Table 68 : Codexis Inc.: News/Key Developments, 2022
• Table 69 : Eurofins Scientific: Company Snapshot
• Table 70 : Eurofins Scientific: Financial Performance, FY 2022 and 2023
• Table 71 : Eurofins Scientific: Product Portfolio
• Table 72 : Eurofins Scientific: News/Key Developments, 2021-2023
• Table 73 : GenScript: Company Snapshot
• Table 74 : GenScript: Financial Performance, FY 2022 and 2023
• Table 75 : GenScript: Product Portfolio
• Table 76 : GenScript: News/Key Developments, 2021-2024
• Table 77 : Ginkgo Bioworks: Company Snapshot
• Table 78 : Ginkgo Bioworks: Financial Performance, FY 2022 and 2023
• Table 79 : Ginkgo Bioworks: Product Portfolio
• Table 80 : Ginkgo Bioworks: News/Key Developments, 2022-2024
• Table 81 : Merck KGaA: Company Snapshot
• Table 82 : Merck KGaA: Financial Performance, FY 2022 and 2023
• Table 83 : Merck KGaA: Product Portfolio
• Table 84 : Merck KGaA: News/Key Developments, 2022-2024
• Table 85 : Thermo Fisher Scientific Inc.: Company Snapshot
• Table 86 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
• Table 87 : Thermo Fisher Scientific Inc.: Product Portfolio
• Table 88 : Thermo Fisher Scientific Inc.: News/Key Developments, 2022-2024
• Table 89 : Twist Bioscience: Company Snapshot
• Table 90 : Twist Bioscience: Financial Performance, FY 2022 and 2023
• Table 91 : Twist Bioscience: Product Portfolio
• Table 92 : Viridos: Company Snapshot
• Table 93 : Viridos: Product Portfolio
• Table 94 : Viridos: News/Key Developments, 2022-2023

List of Figures

• Summary Figure : Global Market for Synthetic Biology, by Product Type, 2021-2029
• Figure 1 : Value Chain Analysis: Synthetic Biology Market
• Figure 2 : Synthetic Biology: Value-Added Chain
• Figure 3 : Chart Outlining U.S. Regulatory Agencies that Regulate Specific GEMs
• Figure 4 : Market Dynamics of Synthetic Biology Industry
• Figure 5 : Funding in Synthetic Biology Sector, 2009-2020
• Figure 6 : Global Biofuel Demand, Trends and Projections, 2016-2028
• Figure 7 : Patents Documented, by Legal Status, 2020-2024
• Figure 8 : Top IPCR Classification Codes, 2020-2024
• Figure 9 : Global Synthetic Biology Market Share, by Product Type, 2023
• Figure 10 : Global Synthetic Biology Market Share for Enabled Products, by Region, 2023
• Figure 11 : Global Synthetic Biology Market Share for Enabling Products, by Product Type, 2023
• Figure 12 : Global Synthetic Biology Market Share for Enabling Products, by Region, 2023
• Figure 13 : Global Synthetic Biology Market Share for Biologic Components, by Product Type, 2023
• Figure 14 : Global Synthetic Biology Market Share for Biologic Components, by Region, 2023
• Figure 15 : Global Synthetic Biology Market Share for Integrated Systems, by Product Type, 2023
• Figure 16 : Global Synthetic Biology Market Share for Integrated Systems, by Region, 2023
• Figure 17 : Global Synthetic Biology Market Share, by End User, 2023
• Figure 18 : Global Synthetic Biology Enabled Product Market Share, by End User, 2023
• Figure 19 : Global Synthetic Biology Healthcare Market Share, by Sector, 2023
• Figure 20 : Global Synthetic Biology Consumer Products Market Share, by Sector, 2023
• Figure 21 : Global Synthetic Biology Food and Beverage Market Share, by Sector, 2023
• Figure 22 : Global Synthetic Biology Industrial Chemicals Market Share, by Sector, 2023
• Figure 23 : Global Synthetic Biology Agriculture Market Share, by Sector, 2023
• Figure 24 : Global Synthetic Biology Enabling Product Market Share, by End User, 2023
• Figure 25 : Global Synthetic Biology Biologic Component Market Share, by End User, 2023
• Figure 26 : Global Synthetic Biology Integrated Systems Market Share, by End User, 2023
• Figure 27 : Global Synthetic Biology Market Share, by Region, 2023
• Figure 28 : North American Synthetic Biology Market Share, by Country, 2023
• Figure 29 : European Synthetic Biology Market Share, by Country, 2023
• Figure 30 : Asia-Pacific Synthetic Biology Market Share, by Country, 2023
• Figure 31 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
• Figure 32 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
• Figure 33 : Codexis Inc.: Revenue Share, by Business Unit, FY 2023
• Figure 34 : Codexis Inc.: Revenue Share, by Country/Region, FY 2023
• Figure 35 : Eurofins Scientific: Revenue Share, by Business Unit, FY 2023
• Figure 36 : Eurofins Scientific: Revenue Share, by Country/Region, FY 2023
• Figure 37 : GenScript: Revenue Share, by Business Unit, FY 2023
• Figure 38 : GenScript: Revenue Share, by Country/Region, FY 2023
• Figure 39 : Ginkgo Bioworks: Revenue Share, by Business Unit, FY 2023
• Figure 40 : Merck KGaA: Revenue Share, by Business Unit, FY 2023
• Figure 41 : Merck KGaA: Revenue Share, by Country/Region, FY 2023
• Figure 42 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
• Figure 43 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023
• Figure 44 : Twist Bioscience: Revenue Share, by Business Unit, FY 2023
• Figure 45 : Twist Bioscience: Revenue Share, by Country/Region, FY 2023

The global market for synthetic biology products was valued at $15.4 billion in 2023. The market is projected to grow from $19.3 billion in 2024 to $61.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 26.1% from 2024 through 2029.

The global synthetic biology market for enabled products is projected to grow from $10.1 billion in 2024 to $34.8 billion by the end of 2029, at a CAGR of 28.0% from 2024 through 2029.

The global synthetic biology market for enabling products is projected to grow from $6.8 billion in 2024 to $21.0 billion by the end of 2029, at a CAGR of 25.1% from 2024 through 2029.

Report Scope:

The study scope includes core synthetic biology products (e.g., oligonucleotides, synthetic genes, BioBrick parts, delivery plasmids, chassis organisms, synthetic cells, cell-based and cell-free production systems), enabling technologies (e.g., DNA sequencing, DNA synthesis, gene editing, bioinformatics, specialty media) and enabled technologies (e.g., healthcare, industrial chemicals, consumer products, food and beverage, agriculture) that are already commercialized or are forecast to be commercialized through 2029.

Key synthetic biology technologies and products are analyzed to determine present and future market status, as well as forecasted growth from 2024 through 2029. An in-depth discussion of strategic alliances, industry structures, competitive dynamics, patents, and market-driving forces is also provided.

BCC Research examines the synthetic biology industry by market segment, including DNA sequencing, DNA synthesis, gene editing, synthetic biology foundries, and software. The market is also analyzed by end users, including agriculture, consumer products, cosmetics and skin care, food and beverage, healthcare, and industrial chemicals.

By geographical region, the market is divided into four regions: North America, Europe, Asia-Pacific, and Rest of the World (RoW). For market estimates, data has been provided for 2023 as the base year, with forecasts for 2024 through 2029.

Report Includes:

50 data tables and 45 additional tables

• An analysis of the global markets for synthetic biology products and technologies
• Analyses of global market trends, with market revenue data from 2021 to 2023, estimates for 2024, and projected CAGRs through 2029
• Estimates of the current market size and revenue prospects, along with market share analysis by product type, end-user industry and region
• Facts and figures pertaining to the market drivers and challenges, innovations, technologies, industry regulations, and the influence of macroeconomic factors

Identification of core synthetic biology products, key enabling technologies, commercial opportunities for product development, and competitive strategies

• Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, the ESG practices of leading companies and their ESG scores
• An analysis of patents granted for synthetic biology technologies, liquid biopsy and sequencing, and gene editing
• Analysis of the industry structure, including company market shares, strategic alliances, M&A activity and venture funding outlook
• Profiles of the market leaders, including Ginkgo Bioworks, Amyris, Twist Bioscience, Codexis Inc., and Thermo Fisher Scientific Inc.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Overview
• Value Chain Analysis
• Regulatory Framework
• Regulation of GEMs in the United States
• Impacts of Synthetic Biology on Biodiversity Conservation
• Direct Impacts
• Indirect Impacts

Chapter 3 Market Dynamics

• Overview
• Market Drivers
• Various Applications of Synthetic Biology in Diverse Fields
• Increasing Funding for Research and Development
• Declining Cost of DNA Sequencing
• Continuous Innovations in the Synthetic Biology Field
• Market Restraints
• Biosafety, Biosecurity, and Ethical Issues
• Market Opportunities
• Increasing Demand for Fuel Alternatives
• Use of Machine Learning in Synthetic Biology

Chapter 4 Emerging Trends and Patent Analysis

• Emerging Trends
• CRISPR-Cas Systems
• Gene Drives
• Expanded Genetic Code
• Optogenetics
• Synthetic Genomics
• Cell-Free System
• Microbiome Engineering
• Patent Analysis
• Select Patent Grants
• Patent Review

Chapter 5 Market Segmentation Analysis

• Segmentation Breakdown
• Market Analysis, by Product Type
• Enabled Products
• Enabling Products
• Biologic Components
• Integrated Systems
• Market Analysis, by End User
• Enabled Product, by End User
• Enabling Product, by End User
• Biologic Components, by End User
• Integrated Systems, by End User
• Geographic Breakdown
• Market Analysis, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 6 Competitive Intelligence

• Company Share Analysis
• Investment in Industry

Chapter 7 Sustainability in Synthetic Biology Market: ESG Perspective

• Overview
• ESG Trends in the Biotechnology Industry
• ESG Risks and Challenges
• ESG Perspective
• Environmental Impact
• Social Impact
• Governance and Ethical Considerations

Chapter 8 Appendix

• Methodology
• Sources
• Acronyms
• Company Profiles
• AGILENT TECHNOLOGIES INC.
• AMYRIS
• CODEXIS INC.
• EUROFINS SCIENTIFIC
• GENSCRIPT
• GINKGO BIOWORKS
• MERCK KGAA
• THERMO FISHER SCIENTIFIC INC.
• TWIST BIOSCIENCE
• VIRIDOS